BIVI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BioVie Inc (BIVI) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock lacks positive catalysts, has weak financial performance, and no significant trading signals or trends to support a buy decision. Holding off on this stock is recommended.
The technical indicators suggest a neutral to bearish trend. The MACD histogram is negative and contracting, RSI is neutral at 51.979, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels show limited upward potential with a pivot at 1.361 and resistance at 1.483.
NULL identified. No recent news, no significant insider or hedge fund activity, and no congress trading data.
Weak financial performance in Q2 2026 with a net income drop of -15.19% YoY and EPS down -83.08% YoY. The stock has a 70% chance of a minor 0.57% gain in the next day but a potential -2.26% decline in the next month.
In Q2 2026, the company reported no revenue growth (0% YoY), a net income loss of -$6,069,475 (-15.19% YoY), and a significant EPS decline of -83.08% YoY. Gross margin remains at 0%.
No analyst ratings or price target changes available for review.
